SCHEMBL876915

SCHEMBL876915

O=C(O)C(F)C(F)C(F)C(F)CCCF

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29203317 0.98 MAPT (0.31) MAPT
SCHEMBL28409180 0.92 MAPT (0.37) MAPT
SCHEMBL5690763 0.92 MAPT (0.37) MAPT
SCHEMBL29031281 0.90 MAPT (0.36) MAPT
SCHEMBL27766990 0.86 MAPT (0.38) MAPT
SCHEMBL366788 0.85
SCHEMBL3132073 0.85
SCHEMBL3371717 0.85 MAPT (0.34) MAPT
Hydrochloric Acid SCHEMBL9234992 0.83
Hydrochloric Acid SCHEMBL11748274 0.83 MAPT (0.33) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022142152-A1 CONTENT MEASUREMENT METHOD FOR CLINDAMYCIN PHOSPHATE VAGINAL TABLET 海南海神同洲制药有限公司 2022-07-07 WO claimed
WO-2022142152-A1 CONTENT MEASUREMENT METHOD FOR CLINDAMYCIN PHOSPHATE VAGINAL TABLET 海南海神同洲制药有限公司 2022-07-07 WO disclosed
WO-2021147585-A1 USE OF CHITOSAN MODIFIED BY FLUORINE-CONTAINING COMPOUND AS DRUG CARRIER AND PREPARATION METHOD THEREFOR 苏州大学 2021-07-29 WO disclosed
US-10758490-B2 Nanocapsules containing microemulsions LIPOTEC, S.A. (ES) 2020-09-01 US disclosed
EP-2618926-B1 NANOCAPSULES CONTAINING MICROEMULSIONS LIPOTEC SA (ES) 2019-05-08 EP disclosed
EP-3272398-A1 LIPID NANOPARTICLE CAPSULES Lipotec S.A. (ES) 2018-01-24 EP disclosed
EP-2898774-A1 Composition for the treatment of textile materials Archroma IP GmbH (CH) 2015-07-29 EP disclosed
US-8921515-B2 Methods and compositions of preparation for proteome analysis CASE WESTERN RESERVE UNIVERSITY (US) 2014-12-30 US disclosed
US-20130216596-A1 NANOCAPSULES CONTAINING MICROEMULSIONS LIPOTEC, S.A. (ES) 2013-08-22 US disclosed
EP-2618926-A2 NANOCAPSULES CONTAINING MICROEMULSIONS Lipotec, S.A. (ES) 2013-07-31 EP disclosed
US-20130172539-A1 METHODS AND COMPOSITIONS OF PREPARATION FOR PROTEOME ANALYSIS CASE WESTERN RESERVE UNIVERSITY (US) 2013-07-04 US disclosed
EP-2549977-A2 LIPID NANOPARTICLE CAPSULES Lipotec, S.A. (ES) 2013-01-30 EP disclosed
US-20130017239-A1 LIPID NANOPARTICLE CAPSULES LIPOTEC S.A. (ES) 2013-01-17 US disclosed
WO-2012038061-A2 NANOCAPSULES CONTAINING MICROEMULSIONS LIPOTEC, S.A. (ES) 2012-03-29 WO disclosed
WO-2011116963-A2 LIPID NANOPARTICLE CAPSULES LIPOTEC S.A. (ES) 2011-09-29 WO disclosed